New results were presented this weekend on a PET radiopharmaceutical being developed by Bayer for imaging cardiac amyloidosis. The tracer turned in promising results in a paper presented at ESC 2026 and published simultaneously in JAMA
Brian Casey is a Technical Writer at various prominent publications including Jacobin Magazine and TechCrunch. He covers a diverse range of topics, with a strong focus on construction and real estate, as well as medicine and healthcare, particularly in healthcare technology and telehealth. Brian's work has been featured in notable outlets such as The Irish Times and Electronic Design, showcasing his expertise in both the real estate sector and the evolving landscape of digital health.